Skip to Main content Skip to Navigation
Journal articles

Allergen-derived peptide: A promising approach in asthma

Abstract : Severe asthma required high dose of corticosteroids combined with biotherapies to control more or less asthma symptoms and lead to the decrease of patients' quality of life on long term. Recent studies show that hypoallergenic peptides derived from allergen can prevent airway hyperresponsiveness, decrease Th2 response and also allergen-specific IgE in mouse models of allergic asthma. Even if some peptides mechanisms remain unknown, their fast efficacy with low doses of allergens make peptide immunotherapy a new promising approach in allergic asthma.
Complete list of metadata

https://hal.inrae.fr/hal-02619077
Contributor : Accord Elsevier Ccsd Connect in order to contact the contributor
Submitted on : Friday, October 22, 2021 - 9:36:07 PM
Last modification on : Wednesday, November 3, 2021 - 6:12:52 AM

File

S0761842519300841.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

M. Klein, Axel Magnan, Grégory Bouchaud. Allergen-derived peptide: A promising approach in asthma. Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36 (4), pp.442-446. ⟨10.1016/j.rmr.2019.03.005⟩. ⟨hal-02619077⟩

Share

Metrics

Record views

38

Files downloads

37